FDA Approves Saphris Tablets (asenapine) To Treat Schizophrenia And Bipolar Disorder
Links shared publicly online about this topic.
- 1,819total visits
FDA Approves Saphris Tablets (asenapine) To Treat Schizophrenia And Bipolar Disorder
View full resource at medicalnewstoday.com
Tags: Bipolar Disorder, Schizophrenia, Psychotic Disorder, Disease and Condition, Diet and Nutrition, Drug, FDA
Most Recently Shared on August 16, 2009 at 12:35 pm By:
FDA Approves Saphris Tablets (asenapine) To Treat Schizophrenia And Bipolar Disorder: The U.S. Food and Drug Adm.. http://bit.ly/ePdzL
Merck Receives Approval from FDA for Expanded Indications for Atypical Antipsychotic Medication Saphris (asenapine) Sublingual Tablets
drugs.com — “Saphris (asenapine) is used for the treatment of schizophrenia and bipolar I disorder. Saphris information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on September 14, 2010 at 1:14 am By:
Drugs and Devices OW OW Health
Merck Receives Approval from FDA for Expanded Indications for Atypical Antipsychotic Medication Saphris (asen... http://bit.ly/cBfzbG #drug
FDA Approves Saphris Tablets (asenapine) To Treat Schizophrenia And Bipolar Disorder | Psydir News
news.psydir.com — “The U.S. Food and Drug Administration has approved Saphris tablets (asenapine) to treat adults with schizophrenia, a chronic, severe and disabling brain disorder, and to treat bipolar I disorder in adults, a serious psychiatric disorder that causes shifts in a person's mood, energy, and ability to function.” View full resource at news.psydir.com
Most Recently Shared on August 16, 2009 at 12:31 pm By:
FDA Approves Saphris Tablets (asenapine) To Treat Schizophrenia And Bipolar Disorder http://ow.ly/15Ldfh
Schering-Plough Announces FDA Approval of Saphris (asenapine)
drugs.com — “Saphris (asenapine) is used to treat schizophrenia and bipolar I disorder. Includes Saphris side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 15, 2009 at 6:07 am By:
Schering-Plough Announces FDA Approval of Saphris (asenapine) - http://bit.ly/XvAmd
Saphris approved for schizophrenia and bipolar I disorder - MPR
empr.com — “The FDA has approved Saphris (asenapine sublingual tablets, from Schering-Plough), a psychotropic agent, for the acute treatment of schizophrenia in adults and the acute treatment of manic or mixed episodes associated with bipolar I disorder with or without psychotic features in adults.” View full resource at empr.com
Most Recently Shared on August 14, 2009 at 3:41 pm By:
MPR News: Saphris approved for schizophrenia and bipolar I disorder: The FDA has approved Saphris (asen.. http://bit.ly/A4RkP
Advertisement
